Is BNTC or BOLT more undervalued in 2026?

CirclFi compares Benitec Biopharma Inc. (BNTC) and Bolt Biotherapeutics, Inc. (BOLT) using 13 institutional-grade valuation models. BNTC has a Quality of Company score of 4.4/10 while BOLT scores 5.9/10.

Which is a better buy — BNTC or BOLT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BNTC and BOLT valuations compare?

BNTC at $11.56 and BOLT at $5.30 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BNTC vs BOLT Valuation Comparison 2026 — Intrinsic Value Analysis

BNTC

Biotechnology

Benitec Biopharma Inc.

Quality

4.4

out of 10

Value Trap

WARN

Price

$11.56

Last close

Models

7/13

Active

BOLT

Biotechnology

Bolt Biotherapeutics, Inc.

Quality

5.9

out of 10

Value Trap

LOW

Price

$5.30

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	BNTC Fair Value	BNTC Upside	BOLT Fair Value	BOLT Upside
Bayesian DCF	Intrinsic	$6.04	-47.8%	$0.54	-88.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.75	-93.5%	$17.21	+224.6%
Dynamic NAV	Asset-Based	$5.93	-48.7%	$23.97	+352.2%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BNTC vs BOLT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BNTC vs BOLT — Which Stock Is More Undervalued?

BOLT scores higher with a 5.9/10 quality rating vs BNTC's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Benitec Biopharma Inc. (BNTC) and Bolt Biotherapeutics, Inc. (BOLT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BNTC currently trades at $11.56 with a QOC of 4.4/10, while BOLT trades at $5.30 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).